These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3106616)

  • 1. Ocular pharmacology of methazolamide analogs: distribution in the eye and effects on pressure after topical application.
    Maren TH; Bar-Ilan A; Caster KC; Katritzky AR
    J Pharmacol Exp Ther; 1987 Apr; 241(1):56-63. PubMed ID: 3106616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison between the effect of topical and systemic carbonic anhydrase inhibitors on aqueous humor secretion.
    Brechue WF; Maren TH
    Exp Eye Res; 1993 Jul; 57(1):67-78. PubMed ID: 8405174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics, acid-base balance and intraocular pressure effects of ethyloxaloylazolamide--a novel topically active carbonic anhydrase inhibitor.
    Sharir M; Pierce WM; Chen D; Zimmerman TJ
    Exp Eye Res; 1994 Jan; 58(1):107-16. PubMed ID: 8157096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-Substituted sulfonamide carbonic anhydrase inhibitors with topical effects on intraocular pressure.
    Duffel MW; Ing IS; Segarra TM; Dixson JA; Barfknecht CF; Schoenwald RD
    J Med Chem; 1986 Aug; 29(8):1488-94. PubMed ID: 3735316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-662,583 is a topically effective ocular hypotensive carbonic anhydrase inhibitor in experimental animals.
    Sugrue MF; Gautheron P; Mallorga P; Nolan TE; Graham SL; Schwam H; Shepard KL; Smith RL
    Br J Pharmacol; 1990 Jan; 99(1):59-64. PubMed ID: 2110013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and physicochemical properties of thiadiazolo[3,2-a]pyrimidinesulfonamides and thiadiazolo[3,2-a]triazinesulfonamides as candidates for topically effective carbonic anhydrase inhibitors.
    Katritzky AR; Caster KC; Maren TH; Conroy CW; Bar-Ilan A
    J Med Chem; 1987 Nov; 30(11):2058-62. PubMed ID: 3669014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbonic anhydrase inhibitors. Synthesis of water-soluble, topically effective, intraocular pressure-lowering aromatic/heterocyclic sulfonamides containing cationic or anionic moieties: is the tail more important than the ring?
    Scozzafava A; Menabuoni L; Mincione F; Briganti F; Mincione G; Supuran CT
    J Med Chem; 1999 Jul; 42(14):2641-50. PubMed ID: 10411484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of carbonic anhydrase inhibitors on aqueous humor chemistry and dynamics.
    Bar-Ilan A; Pessah NI; Maren TH
    Invest Ophthalmol Vis Sci; 1984 Oct; 25(10):1198-205. PubMed ID: 6434487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetazolamide-like carbonic anhydrase inhibitors with topical ocular hypotensive activity.
    Antonaroli S; Bianco A; Brufani M; Cellai L; Lo Baido G; Potier E; Bonomi L; Perfetti S; Fiaschi AI; Segre G
    J Med Chem; 1992 Jul; 35(14):2697-703. PubMed ID: 1635066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of melanin binding and metabolism in the activity of 5-acetoxyacetylimino-4-methyl-delta2-1,3,4,-thiadiazolin e-2-sulfonamide.
    Schoenwald RD; Tandon V; Wurster DE; Barfknecht CF
    Eur J Pharm Biopharm; 1998 Jul; 46(1):39-50. PubMed ID: 9700021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of intraocular pressure lowering by topical and systemic carbonic anhydrase inhibitors in the rabbit.
    Fanous MM; Challa P; Maren TH
    J Ocul Pharmacol Ther; 1999 Feb; 15(1):51-7. PubMed ID: 10048347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbonic anhydrase inhibitors. Water-soluble, topically effective intraocular pressure lowering agents derived from isonicotinic acid and aromatic/heterocyclic sulfonamides: is the tail more important than the ring?
    Menabuoni L; Scozzafava A; Mincione F; Briganti F; Mincione G; Supuran CT
    J Enzyme Inhib; 1999; 14(6):457-74. PubMed ID: 10536879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of topical and general anesthesia on ocular drug levels and intraocular pressure lowering activity of topically applied carbonic anhydrase inhibitors.
    Bar-Ilan A; Pessah NI
    J Ocul Pharmacol; 1988; 4(1):1-12. PubMed ID: 3171330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thieno[2,3-b]furan-2-sulfonamides as topical carbonic anhydrase inhibitors.
    Hartman GD; Halczenko W; Prugh JD; Smith RL; Sugrue MF; Mallorga P; Michelson SR; Randall WC; Schwam H; Sondey JM
    J Med Chem; 1992 Aug; 35(16):3027-33. PubMed ID: 1501230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacology of methazolamide in relation to the treatment of glaucoma.
    Maren TH; Haywood JR; Chapman SK; Zimmerman TJ
    Invest Ophthalmol Vis Sci; 1977 Aug; 16(8):730-42. PubMed ID: 407172
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of topically administered carbonic anhydrase inhibitors on aqueous humor dynamics in rabbits.
    Stein A; Pinke R; Krupin T; Glabb E; Podos SM; Serle J; Maren TH
    Am J Ophthalmol; 1983 Feb; 95(2):222-8. PubMed ID: 6824053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose methazolamide and intraocular pressure.
    Stone RA; Zimmerman TJ; Shin DH; Becker B; Kass MA
    Am J Ophthalmol; 1977 May; 83(5):674-9. PubMed ID: 17301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the pharmacology of L-645,151: a topically effective ocular hypotensive carbonic anhydrase inhibitor.
    Sugrue MF; Gautheron P; Schmitt C; Viader MP; Conquet P; Smith RL; Share NN; Stone CA
    J Pharmacol Exp Ther; 1985 Feb; 232(2):534-40. PubMed ID: 3838190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular hypotensive activity and disposition of the topical carbonic anhydrase inhibitor 6-hydroxy-benzo[b]thiophene-2-sulfonamide, L-650,719, in the rabbit.
    Bar-Ilan A; Pessah NI; Maren TH
    J Ocul Pharmacol; 1989; 5(2):99-110. PubMed ID: 2754300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methazolamide 1% in cyclodextrin solution lowers IOP in human ocular hypertension.
    Gudmundsdóttir E; Stefánsson E; Bjarnadóttir G; Sigurjónsdóttir JF; Gudmundsdóttir G; Masson M; Loftsson T
    Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3552-4. PubMed ID: 11006251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.